MYELOID AND LYMPHOID RECOVERY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A COMPARATIVE-STUDY BETWEEN RELATED, UNRELATED BONE-MARROWAND ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION
R. Trenschel et al., MYELOID AND LYMPHOID RECOVERY FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A COMPARATIVE-STUDY BETWEEN RELATED, UNRELATED BONE-MARROWAND ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION, Leukemia & lymphoma, 30(3-4), 1998, pp. 325-352
We studied myeloid and lymphoid recovery during a period of 12 months
following HLA matched allogeneic bone marrow transplantation (BMT) in
15 patients. Patients were divided into three groups. Each group conta
ined 5 patients according to the source of hematopoietic stem cell tra
nsplantation (HST): 1) related bone marrow transplantation (BMT), 2) a
llogeneic peripheral blood stem cell transplantation (PBSCT) and 3) ma
tched unrelated donor transplantation (MUD). The rate and pattern of r
ecovery of granulocytes, lymphocytes (T-cell subsets, B-cells, Mt cell
s, subsets of CD45) were studied by cell counting and flow cytometry.
Our results suggest faster recovery of PMN after PBSCT. Higher CD4 cel
l counts observed in the PBSCT group may have an impact on a lower inc
idence of opportunistic infections. Chronic GVHD mediated GvL effect s
eems to be more important in blood stem cell transplanted patients and
this may have an influence on disease free survival.